Showing results (51-60 of 3,007) with videos related to
Sort By:
Pageof 301
Antimicrobial Agents and Chemotherapy|October 31, 1998
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistanceY Dong, C Xu, X Zhao, et al.Antimicrobial Agents and Chemotherapy|July 18, 2000
Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesisB Fournier, X Zhao, T Lu, et al.Journal of Molecular Biology|June 12, 2001
gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivityJ G Heddle, T Lu, X Zhao, et al.Molecular Microbiology|November 1, 1993
Topoisomerase mutations affect the relative abundance of many Escherichia coli proteinsT R Steck, R J Franco, J Y Wang, et al.Gene|May 23, 1998
Topoisomerase I of Helicobacter pylori: juxtaposition with a flagellin gene (flaB) and functional requirement of a fourth zinc finger motifS Suerbaum, T Brauer-Steppkes, A Labigne, et al.The Journal of Biological Chemistry|March 5, 1989
Reconstitution of periplasmic transport in inside-out membrane vesicles. Energization by ATPG F Ames, K Nikaido, J Groarke, et al.Antimicrobial Agents and Chemotherapy|July 1, 1996
Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosityK Drlica, C Xu, J Y Wang, et al.The Journal of Infectious Diseases|November 1, 1996
Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosisC Xu, B N Kreiswirth, S Sreevatsan, et al.Journal of Bacteriology|May 1, 1984
DNA supercoiling in gyrase mutantsT R Steck, G J Pruss, S H Manes, et al.Nucleic Acids Research|December 25, 1994
In vivo decay kinetic parameters of hammerhead ribozymesM Sioud, A Opstad, J Q Zhao, et al.Pageof 301